Back to search

Article

Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response.

2023-02-02

Abstract excerpt

<h4>Background: </h4> and Purpose: Colorectal cancer (CRC) is one of the cancers with the highest incidence in which APC gene mutations occurs in almost 80% of patients. This mutation leads to β-catenin aberrant accumulation and an uncontrolled proliferation. Apoptosis evasion, changes in the immune response and microbiota composition are also events that arise in CRC. Tetracyclines are drugs with proven antibioti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2f9b6ef-5ca4-50ab-b0b3-9815ac6afee1
DOI
10.22541/au.167535386.67797512/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response.DOI 10.22541/au.167535386.67797512/v1
Select a neighboring publication to make it the new centre.